DAVID POPLACK to Amifostine
This is a "connection" page, showing publications DAVID POPLACK has written about Amifostine.
Connection Strength
0.127
-
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Cancer Res. 1995 Sep 15; 55(18):4069-72.
Score: 0.127
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.